Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.

Ploussard G, Nicolaiew N, Marchand C, Terry S, Vacherot F, Vordos D, Allory Y, Abbou CC, Salomon L, de la Taille A.

Eur Urol. 2014 Jan;65(1):154-61. doi: 10.1016/j.eururo.2012.05.049. Epub 2012 Jun 9.

PMID:
22698576
[PubMed - indexed for MEDLINE]
2.

Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis.

Jiang X, Zhu S, Feng G, Zhang Z, Li C, Li H, Wang C, Xu Y.

Eur Urol. 2013 Jun;63(6):1031-9. doi: 10.1016/j.eururo.2013.01.035. Epub 2013 Feb 10. Review.

PMID:
23414775
[PubMed - indexed for MEDLINE]
3.

Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.

Guichard G, Larré S, Gallina A, Lazar A, Faucon H, Chemama S, Allory Y, Patard JJ, Vordos D, Hoznek A, Yiou R, Salomon L, Abbou CC, de la Taille A.

Eur Urol. 2007 Aug;52(2):430-5. Epub 2007 Mar 13.

PMID:
17412489
[PubMed - indexed for MEDLINE]
4.

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.

Guazzoni G, Nava L, Lazzeri M, Scattoni V, Lughezzani G, Maccagnano C, Dorigatti F, Ceriotti F, Pontillo M, Bini V, Freschi M, Montorsi F, Rigatti P.

Eur Urol. 2011 Aug;60(2):214-22. doi: 10.1016/j.eururo.2011.03.052. Epub 2011 Apr 5.

PMID:
21482022
[PubMed - indexed for MEDLINE]
5.

The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.

Scattoni V, Raber M, Capitanio U, Abdollah F, Roscigno M, Angiolilli D, Maccagnano C, Gallina A, Saccà A, Freschi M, Doglioni C, Rigatti P, Montorsi F.

Eur Urol. 2011 Oct;60(4):834-41. doi: 10.1016/j.eururo.2011.07.036. Epub 2011 Jul 30.

PMID:
21820797
[PubMed - indexed for MEDLINE]
6.

Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.

Scattoni V, Raber M, Abdollah F, Roscigno M, Dehò F, Angiolilli D, Maccagnano C, Gallina A, Capitanio U, Freschi M, Doglioni C, Rigatti P, Montorsi F.

Eur Urol. 2010 Jan;57(1):1-8. doi: 10.1016/j.eururo.2009.08.011. Epub 2009 Aug 19.

PMID:
19720449
[PubMed - indexed for MEDLINE]
7.

Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.

Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H.

J Urol. 2005 May;173(5):1536-40.

PMID:
15821481
[PubMed - indexed for MEDLINE]
8.

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care.

Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS.

Eur Urol. 2013 Feb;63(2):214-30. doi: 10.1016/j.eururo.2012.09.033. Epub 2012 Sep 25. Review.

PMID:
23021971
[PubMed - indexed for MEDLINE]
9.

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS.

J Urol. 2013 Jun;189(6):2039-46. doi: 10.1016/j.juro.2013.02.072. Epub 2013 Feb 26. Review.

PMID:
23485507
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.

Ploussard G, Nicolaiew N, Marchand C, Terry S, Allory Y, Vacherot F, Abbou CC, Salomon L, de la Taille A.

BJU Int. 2013 May;111(6):988-96. doi: 10.1111/j.1464-410X.2012.11607.x. Epub 2013 Mar 4.

PMID:
23452046
[PubMed - indexed for MEDLINE]
11.

The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy.

Ficarra V, Novella G, Novara G, Galfano A, Pea M, Martignoni G, Artibani W.

Eur Urol. 2005 Dec;48(6):932-7. Epub 2005 Sep 16.

PMID:
16202510
[PubMed - indexed for MEDLINE]
12.

[Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].

Damiano R, Oliva A, Cantiello F, Esposito C, Perdonà S, De Sio M, Bitonti M, Sacco R, D'Armiento M.

Arch Ital Urol Androl. 2003 Mar;75(1):40-5. Italian.

PMID:
12741345
[PubMed - indexed for MEDLINE]
13.

Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.

Oh JJ, Hong SK, Lee JK, Lee BK, Lee S, Kwon OS, Byun SS, Lee SE.

BJU Int. 2012 Dec;110(11 Pt B):E494-9. doi: 10.1111/j.1464-410X.2012.11182.x. Epub 2012 Apr 30.

PMID:
22540236
[PubMed - indexed for MEDLINE]
14.

The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique.

Eskicorapci SY, Guliyev F, Islamoglu E, Ergen A, Ozen H.

Int Urol Nephrol. 2007;39(1):189-95. Epub 2006 Jun 1.

PMID:
16835725
[PubMed - indexed for MEDLINE]
15.

Detection of prostate cancer: comparison of cancer detection rates of sextant and extended ten-core biopsy protocols.

Ojewola RW, Tijani KH, Jeje EA, Anunobi CC, Ogunjimi MA, Ezenwa EV, Ogundiniyi OS.

Niger Postgrad Med J. 2012 Sep;19(3):137-42.

PMID:
23064168
[PubMed - indexed for MEDLINE]
16.

Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol.

Ouzaid I, Xylinas E, Campeggi A, Hoznek A, Vordos D, Abbou CC, Vacherot F, Salomon L, de la Taille A, Ploussard G.

World J Urol. 2013 Aug;31(4):869-74. doi: 10.1007/s00345-011-0800-2. Epub 2011 Nov 25.

PMID:
22116600
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer.

Eskicorapci SY, Baydar DE, Akbal C, Sofikerim M, Günay M, Ekici S, Ozen H.

Eur Urol. 2004 Apr;45(4):444-8; discussion 448-9.

PMID:
15041107
[PubMed - indexed for MEDLINE]
18.

7 to 10 years' follow-up of 573 patients with elevated prostate-specific antigen (>4 ng/mL) or/and suspected rectal examination: biopsies protocol and follow-up guides.

Kravchick S, Cytron S, Stepnov E, Ben-Dor D, Kravchenko Y, Peled R.

J Endourol. 2009 Jun;23(6):1007-13. doi: 10.1089/end.2008.0260.

PMID:
19456240
[PubMed - indexed for MEDLINE]
19.

Is extended biopsy protocol justified in all patients with suspected prostate cancer?

Ojewola RW, Tijani KH, Jeje EA, Anunobi CC, Ogunjimi MA, Ezenwa EV, Ogundiniyi OS.

Niger J Clin Pract. 2012 Jul-Sep;15(3):315-9. doi: 10.4103/1119-3077.100630.

PMID:
22960968
[PubMed - indexed for MEDLINE]
Free Article
20.

The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.

Nomikos M, Karyotis I, Phillipou P, Constadinides C, Delakas D.

Int Braz J Urol. 2011 Jan-Feb;37(1):87-93; discussion 93.

PMID:
21385484
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk